Looking at the past week, we sure had a lot of turbulence news wise yet whole lot of nothing from this market.    Being a trader in this market environment, we have to accept what's happening out there and constantly adjust our game plan in order to cope with what's working.   Basically, it was a grind out there and whole lot of time was spent on watching things that may not develop.   Well, this is one part of the trading world that we have to accept and we just have to deal with it to the best of our ability.    Because our trading methodology is very short term and most of our plays don't last longer than a couple of days or weeks, we always tend to assess the situation bear in mind our trading time frame.    One good thing is that last week is in the book and we are setting our eyes on a fresh week.   We are also getting closer to te earning season.    While a few little biotechs dominated the stories last week, we still had a few DJIM type of stocks making some nice moves.

MFW, this is probably the result of a long base forming action.  This one held up reasonably well during the correction and it caught our eye earlier this week on a breakout setup.   It did not disappoint and closed the week near another 52 week high.   We are definitely keeping this one on top of our trading list for the next little while.

CYNO, despite the minor pullback on Friday, we think this one is still very much in play.   The 9 ema is catching up which should provide support for this one to gain some footing for possibly another assault higher. We will look to play again. For those new to DJIM, this stock was an alert before being added to IBD back on Feb 15- CYNO, "Accumulating some of this one. Reported recently. Like chart, IBD #'s and float. Low 23's"..Posted on Thursday, February 15, 2007 at 01:49PM

JSDA, so Cramer jumped on this bandwagon and we are definitely putting this one on top of the trading play list at least the next couple of days.   Despite how much you like or dislike this TV guru, we think he can bring enough exposure to this stock for us to get a couple of "easy" tradable opportunities. Also, it was one of the biggest decliners in IBD last week, so look for some support.

TGX MTOX,  A couple of the best performers Friday are past DJIM EPS stocks . Some of you have definitely kept a closer eye on these two than us.    Given all the biotechs news we had last week, it's understandable that these small medial equip. co. can also be put in play.   We've always been partial to this sector and many of our past winners have come from this sector.    Yes, these ones are back onto the top of our trading list. This recent IBD addition has a column on it in weekends edition. As you know we are not shy about buying moves already made.

TGX was a earning play just below $4 in Alerts on Jan 30. here is a refresher on it...Briefingcom- After being a momentum stock in the late 90's, Theragenics fell sharply a few years ago and went through a restructuring and fell off the radar. However, the stock is showing signs of life again and could be making a comeback. Yesterday, the stock traded to a multi-year high following a strong Q4 report. Sometimes a big qtr can put a little company on the map for a sustained move. The co is a medical device maker and it's the brachytherapy segment that is the driver here: its TheraSeed device is used to treat prostate cancer without the drawbacks of surgery. Brachytherapy with the TheraSeed device involves a simple 45-minute, one-time procedure. Typically, a patient receives local anesthesia and does not feel anything below the waist. The physician then inserts thin, hollow needles into the prostate gland and deposits about 75-150 tiny seeds. Most patients leave the hospital within hours and resume routine activities in 2-3 days. During the next few months, the radioactive ingredient, palladium-103 (Pd-103), fights cancer from inside the body. The co says its treatment produces results better or equal to surgery... TGX's Q4 results were impressive with revenue rising 30% yr/yr to $14.8 mln and EPS of $0.05, ex-items, vs a loss a year ago. The co has now delivered four consecutive profitable quarters for the first time since 2002. The co also says it benefits from an important federal health law signed last month which protects reimbursement rates for seeds... Bottom line, TGX moved up on this report, but it still has a market cap of just $143 mln. A strong qtr can put a little known stock on the map, so it's a name to watch as it attempts a comeback. Mkt cap

WBD, we added a small piece on Friday after noting it on Thursday following earning. WBD was an original buy on DJIM back in mid '60. What a nice hold it would have been to today. We are looking to add if this trend continues, we would be sellers not much lower than our pick up in the 79's.

Solars, crude oil definitely stole the spotlight last week.   One would think solar plays would catch some fire as well.  Well, we think it's just a matter of time.   Now we just wait.    The point is, we just can not afford NOT to keep a close eye on these solars.

Let`s get earning season into gear.......

Plenty of nice money making  EPS plays started here last Q including USAP CCF VTRU VARI MTRX SYNL EML HDNG CYNO TRT..again HURC  micro caps TRCR TGX NWK AVZA CSV

Note: We will not be processing renewals or re-activating turned off accounts for those who (signed up Jan 3 or before) during trading hours.